Effect of Mulligans Mobilization With Movement in Osteoarthritis Knee.

September 14, 2025 updated by: Shahnaz Hasan, PhD, Majmaah University

Effect of Mulligan's Mobilization With Movement Added With Isometric Exercises on Muscle Strength Pain and Disability Associated With Knee Osteoarthritis: A Randomized Controlled Study

To evaluate the effect of Mulligan's mobilization with movement in osteoarthritis of the knee.

Study Overview

Detailed Description

Patients with knee OA diagnosed at the orthopaedic clinic of Tumair general hospital and referred to the physiotherapy department who attended the rehabilitation centre of Majmaah university will be recruited.

Patients will be excluded if they have had a knee or hip injury, sensory deficits in the lower extremity, a history of lower-extremity surgery, a history of a quadriceps or hamstring muscle injury, low back-related leg pain, or any contraindication to manual therapy.

The protocol was submitted to and approved by the Rehabilitation Research Chair, King Saud University Research Ethics Committee (RRC-2021-17)

Participants will be requested to sign a written informed consent form approved by the institutional ethics committee. A total of 60 participants were randomly assigned to group A (experimental group): Mulligan's mobilization with movement MWM added isometric strength training, and group B (control group): Sham MWM added isometric strength training. Pre and post-test readings were taken at baseline, week 2, and week 4, respectively. The outcome measures for this study will be maximal voluntary isometric contraction of quadriceps strength (measured by ISOMOVE dynamometer), ROM, and Western Ontario and McMaster universities osteoarthritis (WOMAC) index.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Riyadh Region
      • Al Majma'ah, Riyadh Region, Saudi Arabia, 15341
        • Rehabilitation center, Majmaah University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

36 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient with knee OA with radiological evidence of grade 2 or 3 of the Kellgren and Lawrence scale.
  • Age between 40-65 years, unilateral or bilateral involvement (in the case of bilateral involvement, the more symptomatic knee was included), and pain in and around the knee.

Exclusion Criteria:

  • Patient will be excluded, if they had any deformity of the knee, hip, or back, had any central or peripheral nervous system involvement.
  • They had received steroids or intra-articular injection within the previous three months, uncooperative patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Mulligan's mobilization with movement added isometric strength training will be given 3 days a week for six weeks.

Mulligan's mobilization with movement added isometric exercise:

the participants in the experimental group will receive a Mulligan's mobilization with movement added isometric exercise.

Treatment will be given for the period of three weeks, for five days a week in both groups.

Data will be collected before intervention and after 2nd & 4th week of intervention.

Other Names:
  • Sham MWM added isometric strength training
Active Comparator: Control Group
Mobilization-added isometric strength training will be given 3 days a week for six weeks.

Mulligan's mobilization with movement added isometric exercise:

the participants in the experimental group will receive a Mulligan's mobilization with movement added isometric exercise.

Treatment will be given for the period of three weeks, for five days a week in both groups.

Data will be collected before intervention and after 2nd & 4th week of intervention.

Other Names:
  • Sham MWM added isometric strength training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: 6 weeks
Visual Analogue scale on 0 to10 cm
6 weeks
Range of Motion
Time Frame: 6 weeks
Standard goniometer.
6 weeks
Western Ontario and McMaster universities osteoarthritis (WOMAC) index
Time Frame: 6 weeks
Western Ontario and McMaster universities osteoarthritis scale
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shahnaz Hasan, PhD, Majmah University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2022

Primary Completion (Actual)

November 10, 2023

Study Completion (Actual)

November 14, 2023

Study Registration Dates

First Submitted

December 7, 2021

First Submitted That Met QC Criteria

October 10, 2022

First Posted (Actual)

October 13, 2022

Study Record Updates

Last Update Posted (Estimated)

September 18, 2025

Last Update Submitted That Met QC Criteria

September 14, 2025

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • RRC-2021-17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be kept secure with the principal investigator (Dr. Shahnaz Hasan) and sub-investigator (Dr. Naiyer Shahzad) due to confidentiality issues.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteo Arthritis Knee

Clinical Trials on Mulligan's mobilization with movement MWM added isometric strength training

Subscribe